Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 4

Current treatment options in the management of chronic prostatitis

Authors Alain Jean Duclos, Chun-Te Lee, Daniel Arthur Shoskes

Published 15 September 2007 Volume 2007:3(4) Pages 507—512

Alain Jean Duclos, Chun-Te Lee, Daniel Arthur Shoskes

Glickman Urological Institute, The Cleveland Clinic, 9500 Euclid Ave, Cleveland OH 44195, USA

Abstract: Chronic prostatitis is a disease with an unknown etiology that affects a large number of men. The optimal management for category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is unknown. The recent years have seen a significant increase in research efforts to understand, classify and treat CP/CPPS. Standard treatment usually consists of prolonged courses of antibiotics, even though well-designed clinical trials have failed to demonstrate their efficacy. Recent treatment strategies with some evidence of efficacy include: alpha-blockers, anti-inflammatory agents, hormonal manipulation, phytotherapy (quercetin, bee pollen), physiotherapy and chronic pain therapy. A stepwise, multimodal approach can be successful for the majority of patients who present with this difficult condition.

Keywords: prostatitis, chronic, treatment, management, CPPS

Download Article [PDF] 

Readers of this article also read:

Comparison of three screening tests for autism in preterm children with birth weights less than 1,500 grams

Dudova I, Markova D, Kasparova M, Zemankova J, Beranova S, Urbanek T, Hrdlicka M

Neuropsychiatric Disease and Treatment 2014, 10:2201-2208

Published Date: 17 November 2014

ER-α36: a novel biomarker and potential therapeutic target in breast cancer

Su XY, Xu X, Li GL, Lin BY, Cao J, Teng LS

OncoTargets and Therapy 2014, 7:1525-1533

Published Date: 30 August 2014

A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder

Maneeton N, Maneeton B, Intaprasert S, Woottiluk P

Neuropsychiatric Disease and Treatment 2014, 10:1439-1449

Published Date: 1 August 2014

Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies

Kaur R, Chitanda JM, Michel D, Maley J, Borondics F, Yang P, Verrall RE, Badea I

International Journal of Nanomedicine 2012, 7:3851-3866

Published Date: 19 July 2012

Evaluation of atherosclerotic lesions using dextran- and mannan–dextran-coated USPIO: MRI analysis and pathological findings

Tsuchiya K, Nitta N, Sonoda A, Nitta-Seko A, Ohta S, Takahashi M, Murata K, Mukaisho K, Shiomi M, Tabata Y, Nohara S

International Journal of Nanomedicine 2012, 7:2271-2280

Published Date: 3 May 2012

Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma

Daphne C Richter, James R Joubert, Haylene Nell, Mace M Schuurmans, Elvis M Irusen

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:693-699

Published Date: 5 December 2008

Attention-deficit-hyperactivity disorder and reward deficiency syndrome

Kenneth Blum, Amanda Lih-Chuan Chen, Eric R Braverman, David E Comings, Thomas JH Chen, et al

Neuropsychiatric Disease and Treatment 2008, 4:893-917

Published Date: 10 October 2008